Explore 3 Stock Ideas & Industry Insights Download Free Report

18889881171
Shopping Cart 0
countryflagUS
Login

Milestone Scientific

Healthcare US MLSS

0.3301USD
-0.0412(11.10%)

Last update at 2026-06-22T20:10:00Z

Day Range

0.330.37
LowHigh

52 Week Range

0.411.35
LowHigh

Fundamentals

  • Previous Close 0.37
  • Market Cap45.07M
  • Volume258040
  • P/E Ratio-
  • Dividend Yield0.74%
  • EBITDA-7.07803M
  • Revenue TTM9.81M
  • Revenue Per Share TTM0.14
  • Gross Profit TTM 6.31M
  • Diluted EPS TTM-0.09

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -8.77287M -7.11869M -7.47120M -7.64344M -7.99912M
Minority interest 0.07M 0.06M -0.09443M -0.05587M -0.26013M
Net income -8.70613M -7.11902M -7.48670M -7.66156M -7.43164M
Selling general administrative 12.51M 12.74M 10.77M 9.53M 10.65M
Selling and marketing expenses - - - - -
Gross profit 4.90M 6.31M 3.62M 5.72M 4.43M
Reconciled depreciation 0.14M 0.07M 0.10M 0.26M 0.88M
Ebit -8.82747M -7.37851M -7.45312M -3.99899M -4.91975M
Ebitda -8.68310M -7.30467M -7.35717M -0.10694M -4.03846M
Depreciation and amortization 0.14M 0.07M 0.10M 3.89M 0.88M
Non operating income net other - - 0.07M -3.64599M 0.00021M
Operating income -8.82747M -7.37851M -7.45312M -3.99899M -7.99934M
Other operating expenses 17.63M 17.68M 12.89M 12.37M 16.08M
Interest expense 0.05M 0.02M 0.13M 7.14M 0.00000M
Tax provision 0.00000M 0.00033M 0.02M 0.02M 0.02M
Interest income - - 0.00671M 0.00154M 0.00745M
Net interest income 0.05M -0.01636M 0.00671M 0.00154M 0.00745M
Extraordinary items - - - - -
Non recurring - - - - 1.54M
Other items - - - - -
Income tax expense -0.06674M 0.00033M 0.02M 0.02M 0.02M
Total revenue 8.81M 10.30M 5.44M 8.37M 9.62M
Total operating expenses 13.73M 13.69M 11.07M 9.72M 10.89M
Cost of revenue 3.91M 3.99M 1.82M 2.66M 5.19M
Total other income expense net 0.05M 0.26M -0.01808M -3.64445M -1.54703M
Discontinued operations - - - - -
Net income from continuing ops -8.77287M -6.87643M -7.38881M -7.66156M -8.02311M
Net income applicable to common shares - -6.81832M -7.33727M -7.52437M -7.43164M
Preferred stock and other adjustments - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Total assets 13.70M 19.81M 19.57M 6.56M 6.40M
Intangible assets 0.23M 0.28M 0.33M 0.38M 0.44M
Earning assets - - - - -
Other current assets 0.44M 0.38M 0.42M 0.54M 0.41M
Total liab 3.70M 3.59M 3.46M 4.93M 4.87M
Total stockholder equity 10.23M 16.37M 16.20M 1.70M 1.54M
Deferred long term liab - - - - -
Other current liab 2.10M 2.23M 1.80M 3.19M 1.48M
Common stock 0.07M 0.07M 0.06M 0.05M 0.04M
Capital stock 0.07M 0.07M 0.06M 0.05M 0.04M
Retained earnings -116.41040M -107.70427M -100.88596M -93.52430M -85.99993M
Other liab - - - - -
Good will - - - - -
Other assets - 0.02M 0.69M 0.04M 0.03M
Cash 8.72M 14.76M 14.22M 1.52M 0.74M
Cash and equivalents - - - - -
Total current liabilities 3.30M 3.10M 2.88M 4.93M 4.87M
Current deferred revenue - - 0.24M 0.34M 0.52M
Net debt -8.21824M -14.17776M -13.28132M -1.50029M -0.74343M
Short term debt 0.10M 0.09M 0.36M 0.02M 1.66M
Short long term debt - - 0.28M - -
Short long term debt total 0.50M 0.59M 0.94M 0.02M -
Other stockholder equity 126.57M 124.00M 117.02M 95.17M 88.29M
Property plant equipment - 0.57M 0.66M 0.04M 0.08M
Total current assets 12.97M 18.93M 18.55M 6.09M 5.86M
Long term investments - - - - -
Net tangible assets - 16.09M 15.87M 1.31M 1.10M
Short term investments - - - - -
Net receivables 0.69M 0.94M 1.08M 1.71M 2.08M
Long term debt - - - - -
Inventory 1.79M 1.54M 2.42M 1.62M 1.92M
Accounts payable 1.10M 0.78M 0.48M 1.38M 1.21M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - -0.09443M -0.06727M -0.01140M
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - - - -0.83618M -0.78868M
Additional paid in capital - - - - -
Common stock total equity - - 0.06M 0.05M 0.04M
Preferred stock total equity - - - - 0.00001M
Retained earnings total equity - - -100.88596M -93.52430M -85.99993M
Treasury stock - - -0.91152M -0.91152M -0.91152M
Accumulated amortization - - - - -
Non currrent assets other 0.02M 0.02M 0.02M 0.04M 0.03M
Deferred long term asset charges - - - - -
Non current assets total 0.73M 0.88M 1.02M 0.46M 0.54M
Capital lease obligations 0.50M 0.59M 0.67M 0.02M -
Long term debt total - - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -0.00853M -0.01519M -0.02144M -0.00992M -0.01542M
Change to liabilities - 0.31M -1.87007M 0.29M 1.53M
Total cashflows from investing activities - -0.01519M -0.02144M -0.00992M -0.01542M
Net borrowings - -0.02473M 0.27M 0.27M 0.27M
Total cash from financing activities -0.00854M 4.57M 19.71M 2.56M -0.25000M
Change to operating activities - -0.25723M 0.23M 1.22M 0.39M
Net income -8.77287M -6.87643M -7.38881M -7.58024M -7.69177M
Change in cash -6.04907M 0.54M 12.71M 0.77M -1.89353M
Begin period cash flow 14.76M 14.22M 1.52M 0.74M 2.64M
End period cash flow 8.72M 14.76M 14.22M 1.52M 0.74M
Total cash from operating activities -6.03200M -4.01758M -6.98493M -1.77929M -1.62811M
Issuance of capital stock - 0.00000M 18.04M 2.22M 0.00000M
Depreciation 0.14M 0.07M 0.10M 0.26M 0.88M
Other cashflows from investing activities - - - - -0.00802M
Dividends paid - - - - -
Change to inventory -0.83312M 0.88M -0.79967M 0.30M 0.91M
Change to account receivables 0.25M 0.14M 0.63M 0.37M -0.63548M
Sale purchase of stock - - 19.45M 2.56M -0.25000M
Other cashflows from financing activities -0.00853M 4.60M 1.68M 0.34M -0.01542M
Change to netincome - 1.66M 2.07M 3.74M 2.16M
Capital expenditures 0.00853M 0.02M 0.02M 0.00992M 0.00740M
Change receivables - - 0.94M 0.30M -0.58707M
Cash flows other operating - - 1.54M 1.07M 1.17M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - 12.71M 0.77M -1.89353M
Change in working capital -0.54972M 1.07M -1.81200M 1.81M 1.77M
Stock based compensation 1.82M 1.58M 0.55M 0.18M 0.41M
Other non cash items 1.33M 0.65M 1.67M 3.55M 2.74M
Free cash flow -6.04052M -4.03277M -7.00637M -1.78920M -1.63551M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
MLSS
Milestone Scientific		 -0.0412 11.10% 0.33 - - 4.64 6.29 4.22 -5.9171
ISRG
Intuitive Surgical Inc		 -3.83 0.94% 402.95 73.05 61.73 19.15 10.25 18.41 59.92
ESLOF
EssilorLuxottica Société anonyme		 -13.86 6.73% 192.00 44.84 27.62 4.07 2.49 3.71 16.04
ESLOY
Essilor International SA		 -5.56 5.46% 96.36 41.68 27.25 3.94 2.45 3.71 16.04
BDX
Becton Dickinson and Company		 -3.27 2.27% 140.71 25.56 12.48 2.59 1.76 2.89 12.55

Reports Covered

Stock Research & News

View All

Profile

Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates in two segments, Dental and Medical. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. The company also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. In addition, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Further, the company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.

Milestone Scientific

425 Eagle Rock Avenue, Roseland, NJ, United States, 07068

Key Executives

Name Title Year Born
Mr. Jan Adriaan Haverhals Pres & CEO 1962
Mr. Leonard A. Osser Founder, Vice Chairman & MD of China Operations 1947
Mr. James McAvinn Sr. VP of Sales & Marketing NA
Mr. Andy Molnar Sr. VP of Global Sales & Bus. Devel. for Dental 1962
Keisha Harcum Controller NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.